Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders.
Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers.
1. Cover image - p. cover 2. Title page - p. cover 3. Table of Contents - p. cover 4. Copyright - p. iv 5. Handbook of Clinical Neurology 3rd Series - p. v 6. Foreword - p. vii 7. Preface - p. ix 8. Contributors - p. xi 9. Chapter 1: Psychiatric manifestations of neurologic diseases: Etiology, phenomenology, and treatment - p. xi 10. Chapter 2: Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia - p. 4 11. Chapter 3: Frontotemporal dementia - p. 32 12. Chapter 4: Therapies for prion diseases - p. 45 13. Chapter 5: Behavioral symptomatology and psychopharmacology of Lewy body dementia - p. 58 14. Chapter 6: Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection - p. 70 15. Chapter 7: Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics - p. 82 16. Chapter 8: Tourette disorder and other tic disorders - p. 121 17. Chapter 9: Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration - p. 152 18. Chapter 10: The psychopharmacology of Huntington disease - p. 177 19. Chapter 11: The psychopharmacology of Wilson disease and other metabolic disorders - p. 189 20. Chapter 12: The psychopharmacology of epilepsy - p. 205 21. Chapter 13: The psychopharmacology of brain vascular disease/poststroke depression - p. 227 22. Chapter 14: The psychopharmacology of pseudobulbar affect - p. 241 23. Chapter 15: Psychopharmacology of traumatic brain injury - p. 251 24. Chapter 16: The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes - p. 267 25. Chapter 17: Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: A multidisciplinary approach - p. 283 26. Chapter 18: Psychopharmacology of multiple sclerosis - p. 307 27. Chapter 19: Psychopharmacology of chronic pain - p. 315 28. Chapter 20: Psychopharmacology of headache and its psychiatric comorbidities - p. 337 29. Chapter 21: Psychopharmacology of sleep disorders - p. 344 30. Chapter 22: Sensory neurologic disorders: Tinnitus - p. 364 31. Chapter 23: Psychopharmacology of neurobehavioral disorders - p. 381 32. Chapter 24: The psychopharmacology of autism spectrum disorder and Rett syndrome - p. 390 33. Chapter 25: The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia - p. 414 34. Index - p. 429
Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders.
Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers.
1. Cover image - p. cover 2. Title page - p. cover 3. Table of Contents - p. cover 4. Copyright - p. iv 5. Handbook of Clinical Neurology 3rd Series - p. v 6. Foreword - p. vii 7. Preface - p. ix 8. Contributors - p. xi 9. Chapter 1: Psychiatric manifestations of neurologic diseases: Etiology, phenomenology, and treatment - p. xi 10. Chapter 2: Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia - p. 4 11. Chapter 3: Frontotemporal dementia - p. 32 12. Chapter 4: Therapies for prion diseases - p. 45 13. Chapter 5: Behavioral symptomatology and psychopharmacology of Lewy body dementia - p. 58 14. Chapter 6: Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection - p. 70 15. Chapter 7: Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics - p. 82 16. Chapter 8: Tourette disorder and other tic disorders - p. 121 17. Chapter 9: Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration - p. 152 18. Chapter 10: The psychopharmacology of Huntington disease - p. 177 19. Chapter 11: The psychopharmacology of Wilson disease and other metabolic disorders - p. 189 20. Chapter 12: The psychopharmacology of epilepsy - p. 205 21. Chapter 13: The psychopharmacology of brain vascular disease/poststroke depression - p. 227 22. Chapter 14: The psychopharmacology of pseudobulbar affect - p. 241 23. Chapter 15: Psychopharmacology of traumatic brain injury - p. 251 24. Chapter 16: The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes - p. 267 25. Chapter 17: Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: A multidisciplinary approach - p. 283 26. Chapter 18: Psychopharmacology of multiple sclerosis - p. 307 27. Chapter 19: Psychopharmacology of chronic pain - p. 315 28. Chapter 20: Psychopharmacology of headache and its psychiatric comorbidities - p. 337 29. Chapter 21: Psychopharmacology of sleep disorders - p. 344 30. Chapter 22: Sensory neurologic disorders: Tinnitus - p. 364 31. Chapter 23: Psychopharmacology of neurobehavioral disorders - p. 381 32. Chapter 24: The psychopharmacology of autism spectrum disorder and Rett syndrome - p. 390 33. Chapter 25: The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia - p. 414 34. Index - p. 429
